176 related articles for article (PubMed ID: 32833540)
21. [Coagulation and fibrinolysis parameters in disseminated intravascular coagulation (DIC)].
Nakagawa T; Saito H; Watanabe Y; Sato M; Murakawa E
Rinsho Byori; 1991 Mar; 39(3):309-14. PubMed ID: 1828842
[TBL] [Abstract][Full Text] [Related]
22. Effects of antithrombin III in patients with disseminated intravascular coagulation diagnosed by newly developed diagnostic criteria for critical illness.
Sawamura A; Gando S; Hayakawa M; Hoshino H; Kubota N; Sugano M
Clin Appl Thromb Hemost; 2009 Oct; 15(5):561-6. PubMed ID: 18840625
[TBL] [Abstract][Full Text] [Related]
23. High plasma fibrinogen level is associated with poor clinical outcome in DIC patients.
Wada H; Mori Y; Okabayashi K; Gabazza EC; Kushiya F; Watanabe M; Nishikawa M; Shiku H; Nobori T
Am J Hematol; 2003 Jan; 72(1):1-7. PubMed ID: 12508260
[TBL] [Abstract][Full Text] [Related]
24. Poor outcome in disseminated intravascular coagulation or thrombotic thrombocytopenic purpura patients with severe vascular endothelial cell injuries.
Wada H; Mori Y; Shimura M; Hiyoyama K; Ioka M; Nakasaki T; Nishikawa M; Nakano M; Kumeda K; Kaneko T; Nakamura S; Shiku H
Am J Hematol; 1998 Jul; 58(3):189-94. PubMed ID: 9662269
[TBL] [Abstract][Full Text] [Related]
25. Effects of antithrombin and gabexate mesilate on disseminated intravascular coagulation: a preliminary study.
Nishiyama T; Kohno Y; Koishi K
Am J Emerg Med; 2012 Sep; 30(7):1219-23. PubMed ID: 22204993
[TBL] [Abstract][Full Text] [Related]
26. Changes in plasma levels of natural anticoagulants in disseminated intravascular coagulation: high prognostic value of antithrombin and protein C in patients with underlying sepsis or severe infection.
Choi Q; Hong KH; Kim JE; Kim HK
Ann Lab Med; 2014 Mar; 34(2):85-91. PubMed ID: 24624342
[TBL] [Abstract][Full Text] [Related]
27. Disseminated intravascular coagulation or acute coagulopathy of trauma shock early after trauma? An observational study.
Johansson PI; Sørensen AM; Perner A; Welling KL; Wanscher M; Larsen CF; Ostrowski SR
Crit Care; 2011; 15(6):R272. PubMed ID: 22087841
[TBL] [Abstract][Full Text] [Related]
28. Heterogeneity in the incidence and clinical manifestations of disseminated intravascular coagulation: a study of 204 cases.
Okajima K; Sakamoto Y; Uchiba M
Am J Hematol; 2000 Nov; 65(3):215-22. PubMed ID: 11074538
[TBL] [Abstract][Full Text] [Related]
29. Acquired antithrombin deficiency following severe traumatic injury: rationale for study of antithrombin supplementation.
Owings JT; Gosselin R
Semin Thromb Hemost; 1997; 23 Suppl 1():17-24. PubMed ID: 9156418
[TBL] [Abstract][Full Text] [Related]
30. Antithrombin supplementation and risk of bleeding in patients with sepsis-associated disseminated intravascular coagulation.
Iba T; Gando S; Saitoh D; Wada H; Di Nisio M; Thachil J
Thromb Res; 2016 Sep; 145():46-50. PubMed ID: 27479532
[TBL] [Abstract][Full Text] [Related]
31. IMPACT OF OBESITY ON ENDOTOXIN-INDUCED DISSEMINATED INTRAVASCULAR COAGULATION.
Duburcq T; Tournoys A; Gnemmi V; Hubert T; Gmyr V; Pattou F; Jourdain M
Shock; 2015 Oct; 44(4):341-7. PubMed ID: 26125085
[TBL] [Abstract][Full Text] [Related]
32. Post-trauma coagulation and fibrinolysis in children suffering from severe cerebro-cranial trauma.
Becker S; Schneider W; Kreuz W; Jacobi G; Scharrer I; Nowak-Göttl U
Eur J Pediatr; 1999 Dec; 158 Suppl 3():S197-202. PubMed ID: 10650869
[TBL] [Abstract][Full Text] [Related]
33. Disseminated intravascular coagulation at an early phase of trauma is associated with consumption coagulopathy and excessive fibrinolysis both by plasmin and neutrophil elastase.
Hayakawa M; Sawamura A; Gando S; Kubota N; Uegaki S; Shimojima H; Sugano M; Ieko M
Surgery; 2011 Feb; 149(2):221-30. PubMed ID: 20655560
[TBL] [Abstract][Full Text] [Related]
34. [Clinical relevance of determination of plasma ATIII and alpha 2 PI activities in patients with DIC--application of the molecular markers for the analysis of pathophysiology of DIC].
Okajima K
Rinsho Byori; 1994 Jan; 42(1):45-55. PubMed ID: 8107283
[TBL] [Abstract][Full Text] [Related]
35. Current drug treatment strategies for disseminated intravascular coagulation.
de Jonge E; Levi M; Stoutenbeek CP; van Deventer SJ
Drugs; 1998 Jun; 55(6):767-77. PubMed ID: 9617592
[TBL] [Abstract][Full Text] [Related]
36. Evaluation the combined diagnostic value of TAT, PIC, tPAIC, and sTM in disseminated intravascular coagulation: A multi-center prospective observational study.
Mei H; Jiang Y; Luo L; Huang R; Su L; Hou M; Wang X; Deng J; Hu Y
Thromb Res; 2019 Jan; 173():20-26. PubMed ID: 30458338
[TBL] [Abstract][Full Text] [Related]
37. Hemostasis during the early stages of trauma: comparison with disseminated intravascular coagulation.
Oshiro A; Yanagida Y; Gando S; Henzan N; Takahashi I; Makise H
Crit Care; 2014 Apr; 18(2):R61. PubMed ID: 24708802
[TBL] [Abstract][Full Text] [Related]
38. Benefit Profile of Thrombomodulin Alfa Combined with Antithrombin Concentrate in Patients with Sepsis-Induced Disseminated Intravascular Coagulation.
Murao A; Kato T; Yamane T; Honda G; Eguchi Y
Clin Appl Thromb Hemost; 2022; 28():10760296221077096. PubMed ID: 35166576
[TBL] [Abstract][Full Text] [Related]
39. Disseminated intravascular coagulation in liver cirrhosis: fact or fiction?
Ben-Ari Z; Osman E; Hutton RA; Burroughs AK
Am J Gastroenterol; 1999 Oct; 94(10):2977-82. PubMed ID: 10520855
[TBL] [Abstract][Full Text] [Related]
40. Risk factors for disseminated intravascular coagulation in patients with lung cancer.
Nakano K; Sugiyama K; Satoh H; Shiromori S; Sugitate K; Arifuku H; Yoshida N; Watanabe H; Tokita S; Wakayama T; Tatewaki M; Souma R; Koyama K; Hirata H; Fukushima Y
Thorac Cancer; 2018 Aug; 9(8):931-938. PubMed ID: 29851300
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
